首页> 外国专利> METHOD FOR SELECTION OF CHILDREN WITH ONSET OF ACUTE PYELONEPHRITIS FOR THE COURSE OF ANTI-RELAPSE THERAPY OF PYELONEPHRITIS

METHOD FOR SELECTION OF CHILDREN WITH ONSET OF ACUTE PYELONEPHRITIS FOR THE COURSE OF ANTI-RELAPSE THERAPY OF PYELONEPHRITIS

机译:肾盂肾炎抗复发治疗过程中急性肾盂肾炎发病的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, namely to pediatrics, nephrology, and can be used to select children with the onset of acute pyelonephritis for a course of anti-relapse therapy of pyelonephritis. A portion of urine is collected in a volume of 5 ml after the toilet of the genitals, before the start of antibiotic therapy, with the determination of the levels of transforming growth factor β1 (TGF-1) and creatinine (Cr) in this portion of urine. If the ratio of TGF-β1 and Cr levels in urine (uTGF-β1/Cr) is more than 5.55 pg/mg, a high risk of developing a recurrent course of pyelonephritis is predicted. a course of therapy with a uroseptic drug.;EFFECT: method provides the ability to obtain reliable information about the high probability of recurrent acute pyelonephritis in children and timely treatment with uroseptics, which allows avoiding subsequent recurrence of pyelonephritis, due to a non-invasive method for assessing the ratio of TGF-β1 and Cr levels in the urine of patients.;1 cl, 1 tbl, 2 ex
机译:田地:医学。物质:发明涉及医学,即儿科,肾脏,并且可用于选择儿童肾盂肾炎的抗复发治疗过程中的急性肾盂肾炎。在抗生素治疗开始之前,在生殖器的厕所后,在菌座之后,在菌座之后收集一部分尿液,在该部分中测定转化生长因子β1(TGF-1)和肌酐(CR)的水平尿液。如果尿液中TGF-β1和Cr水平的比率(UTGF-β1/ Cr)的比例大于5.55 pg / mg,则预测高肾盂肾炎的发育疗程的高风险。用骨科药物治疗疗程。效果:方法提供了获得儿童复发性急性肾盂肾炎的高概率的可靠信息,并及时用骨髓治疗,这允许避免由于非侵入性而避免肾盂肾炎的再现评估患者尿液中TGF-β1和Cr水平比率的方法。; 1 cl,1 tbl,2前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号